+

DK0546038T3 - Indgiftsform til tidsvarierende mønstre for lægemiddelafgivelse - Google Patents

Indgiftsform til tidsvarierende mønstre for lægemiddelafgivelse

Info

Publication number
DK0546038T3
DK0546038T3 DK91915824.6T DK91915824T DK0546038T3 DK 0546038 T3 DK0546038 T3 DK 0546038T3 DK 91915824 T DK91915824 T DK 91915824T DK 0546038 T3 DK0546038 T3 DK 0546038T3
Authority
DK
Denmark
Prior art keywords
dosage form
administration
time
drug delivery
drug
Prior art date
Application number
DK91915824.6T
Other languages
Danish (da)
English (en)
Inventor
Felix Theeuwes
Patrick S-L Wong
Anthony L Kuczynski
Atul Devdatt Ayer
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24302741&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0546038(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of DK0546038T3 publication Critical patent/DK0546038T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Control Of Indicators Other Than Cathode Ray Tubes (AREA)
  • Bus Control (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK91915824.6T 1990-08-31 1991-08-28 Indgiftsform til tidsvarierende mønstre for lægemiddelafgivelse DK0546038T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/576,042 US5156850A (en) 1990-08-31 1990-08-31 Dosage form for time-varying patterns of drug delivery

Publications (1)

Publication Number Publication Date
DK0546038T3 true DK0546038T3 (da) 1994-11-28

Family

ID=24302741

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91915824.6T DK0546038T3 (da) 1990-08-31 1991-08-28 Indgiftsform til tidsvarierende mønstre for lægemiddelafgivelse

Country Status (18)

Country Link
US (2) US5156850A (fr)
EP (1) EP0546038B1 (fr)
JP (1) JP2796433B2 (fr)
KR (1) KR0162106B1 (fr)
AT (1) ATE108999T1 (fr)
AU (1) AU648822B2 (fr)
CA (1) CA2088376C (fr)
DE (1) DE69103153T2 (fr)
DK (1) DK0546038T3 (fr)
ES (1) ES2056660T3 (fr)
FI (1) FI107699B (fr)
IE (1) IE67163B1 (fr)
MX (1) MX9100838A (fr)
NO (1) NO304580B1 (fr)
NZ (1) NZ239574A (fr)
PT (1) PT98802B (fr)
WO (1) WO1992004011A1 (fr)
ZA (1) ZA916802B (fr)

Families Citing this family (117)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6764697B1 (en) * 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
US5160744A (en) * 1991-06-27 1992-11-03 Alza Corporation Verapmil therapy
GB9117361D0 (en) * 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form
FI93924C (fi) * 1991-09-17 1995-06-26 Martti Lauri Antero Marvola Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
US5422122A (en) * 1992-08-04 1995-06-06 Eurand America, Incorporated Controlled release potassium chloride tablet
DE69332081T2 (de) * 1992-09-18 2003-02-06 Yamanouchi Pharmaceutical Co., Ltd. Hydrogelzubereitung mit verzögerter freisetzung
EP0621032B1 (fr) * 1993-04-23 2000-08-09 Novartis AG Dispositif d'administration de médicaments à libération contrôlée
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US5922736A (en) * 1995-12-04 1999-07-13 Celegene Corporation Chronic, bolus administration of D-threo methylphenidate
US5837284A (en) * 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
US6486177B2 (en) * 1995-12-04 2002-11-26 Celgene Corporation Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
US6096339A (en) * 1997-04-04 2000-08-01 Alza Corporation Dosage form, process of making and using same
US6919373B1 (en) * 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
EP0946151B1 (fr) * 1996-11-25 2006-05-10 Alza Corporation Forme posologique a doses croissantes
EP1782798A3 (fr) 1996-11-25 2008-05-21 Alza Corporation Forme posologique à libération de dose croissante
US5788987A (en) 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
IT1291652B1 (it) * 1997-04-24 1999-01-19 Apr Trading Sa Composizioni farmaceutiche a copertura terapeutica programmata
US6962997B1 (en) * 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
DE19747261A1 (de) * 1997-10-25 1999-04-29 Bayer Ag Osmotisches Arzneimittelfreisetzungssystem
US8524277B2 (en) 1998-03-06 2013-09-03 Alza Corporation Extended release dosage form
US5945123A (en) * 1998-04-02 1999-08-31 K-V Pharmaceutical Company Maximizing effectiveness of substances used to improve health and well being
KR100827254B1 (ko) * 1998-06-03 2008-05-07 알자 코포레이션 연장된 약물 치료를 제공하기 위한 방법 및 장치
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
JP2002521347A (ja) * 1998-07-21 2002-07-16 アルペンストック・ホールディングス・リミテッド 陰イオン多糖を含む徐放製剤
US6322819B1 (en) 1998-10-21 2001-11-27 Shire Laboratories, Inc. Oral pulsed dose drug delivery system
EP1126826B3 (fr) 1998-11-02 2019-05-15 Alkermes Pharma Ireland Limited Composition de methylphenidate a liberation modifiee multiparticulaire
US6419960B1 (en) 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US6387403B1 (en) 1999-09-15 2002-05-14 Alza Corporation Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing
US6610674B1 (en) * 1999-09-28 2003-08-26 University Of Pennsylvania Method of treating inflammatory conditions with progesterone analogs
EP1227798A4 (fr) 1999-10-29 2004-06-30 Euro Celtique Sa Formulations d'hydrocodone a liberation lente
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
BR0016707A (pt) 1999-12-23 2002-09-03 Pfizer Prod Inc Forma de dosagem de droga em camadas acionada por hidrogel
DZ3228A1 (fr) * 1999-12-23 2001-07-05 Pfizer Prod Inc Médicament dérivé d'un hydrogel sous forme de pastille
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
KR100960200B1 (ko) 2000-10-30 2010-05-27 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
AU2002320360B2 (en) * 2001-07-10 2005-05-26 Teva Pharmaceutical Industries Ltd. Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
US6863901B2 (en) * 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
US20030125714A1 (en) * 2001-12-18 2003-07-03 Edgren David Emil Dosage form for time-varying patterns of drug delivery
US20040052843A1 (en) * 2001-12-24 2004-03-18 Lerner E. Itzhak Controlled release dosage forms
BR0215413A (pt) * 2001-12-24 2004-12-14 Teva Pharma Formula dosada com um comprimido central de ingrediente ativo encapado em uma capa anular prensada de material em pó ou granulado e processo e conjunto de ferramentas para a sua produção
US20050106249A1 (en) * 2002-04-29 2005-05-19 Stephen Hwang Once-a-day, oral, controlled-release, oxycodone dosage forms
MXPA04010769A (es) * 2002-04-29 2005-07-05 Alza Corp Metodos y formas de dosificacion para suministro controlado de oxicodona.
MXPA04012021A (es) * 2002-05-31 2005-08-16 Johnson & Johnson Formas de dosis y composiciones para la administracion osmotica de dosis variables de oxicodona.
AR039744A1 (es) * 2002-06-26 2005-03-09 Alza Corp Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
US20040005359A1 (en) * 2002-06-27 2004-01-08 Cheng Xiu Xiu Controlled release oral dosage form
US20050208132A1 (en) * 2002-07-29 2005-09-22 Gayatri Sathyan Methods and dosage forms for reducing side effects of benzisozazole derivatives
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
PT1539115E (pt) * 2002-07-29 2008-01-14 Alza Corp Métodos e formas de dosagem para libertação controlada de paliperidona
WO2004010970A1 (fr) * 2002-07-29 2004-02-05 Alza Corporation Formulations et formes posologiques pour une administration controlee de topiramate
WO2004012705A1 (fr) * 2002-07-31 2004-02-12 Phafag Ag Formulation pharmaceutique et son utilisation dans le traitement des maladies de l'oreille interne
US6913768B2 (en) * 2002-09-24 2005-07-05 Shire Laboratories, Inc. Sustained release delivery of amphetamine salts
CA2507522C (fr) 2002-12-13 2015-02-24 Durect Corporation Systeme d'administration de medicaments par voie orale
US20070077301A1 (en) * 2002-12-23 2007-04-05 Meyer Glenn A Venlafaxine osmotic device formulation
US8293799B2 (en) * 2003-12-29 2012-10-23 Osmotica Keresleedelmo és Szolgáltató KFT Osmotic device containing a venlafaxine salt and a salt having an ion in common
US20040166160A1 (en) * 2003-01-14 2004-08-26 Ramkumar Subramanian Methods and dosage forms with modified viscosity layers
WO2004071497A1 (fr) * 2003-02-11 2004-08-26 Alza Corporation Methodes et formes dosifiees presentant une geometrie de couche modifiee
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
EP1653922A2 (fr) * 2003-08-06 2006-05-10 Alza Corporation Administration reguliere de topiramate pendant une periode prolongee a formulation de dispersion amelioree
CA2536507A1 (fr) * 2003-08-22 2005-03-10 Alza Corporation Administration progressive de topiramate sur une duree prolongee
CA2564227A1 (fr) * 2003-09-02 2005-03-10 Alza Corporation Compositions medicamenteuses et formes pharmaceutiques de topiramate
AU2004275816A1 (en) * 2003-09-26 2005-04-07 Alza Corporation Controlled release formulations of opioid and nonopioid analgesics
JP4919801B2 (ja) 2003-09-26 2012-04-18 アルザ・コーポレーシヨン 高い薬剤配合量を提供する薬剤コーティング及びそれを提供する方法
US20050260268A1 (en) * 2003-09-26 2005-11-24 Modi Nishit B Methods and dosage forms for controlled delivery of alprazolam
WO2005030182A1 (fr) 2003-09-26 2005-04-07 Alza Corporation Formulations a liberation commandee presentant un taux croisssant de liberation
AU2004285532A1 (en) * 2003-10-31 2005-05-12 Alza Corporation Administration of levodopa and carbidopa
CN1905856A (zh) * 2003-12-23 2007-01-31 阿尔扎公司 用于增加受控递送的药物组合物的溶解度的方法和剂型
US20050175696A1 (en) * 2003-12-29 2005-08-11 David Edgren Drug granule coatings that impart smear resistance during mechanical compression
MXPA06007510A (es) * 2003-12-29 2009-06-10 Johnson & Johnson Composiciones de farmaco y formas de dosis novedosas de topiramato.
MXPA06007509A (es) * 2003-12-29 2007-10-18 Johnson & Johnson Composiciones de farmaco y formas de dosis novedosas.
US20050239830A1 (en) * 2004-04-26 2005-10-27 Vikram Khetani Methods of diminishing co-abuse potential
US20050287213A1 (en) * 2004-06-28 2005-12-29 Wong Patrick S Dosage forms for low solubility and or low dissolution rate free acid pharmaceutical agents
US8541026B2 (en) * 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
AR053986A1 (es) 2004-12-03 2007-05-30 Osmotica Pharmaceutical Argent Dispositivo osmotico que contiene amantadina y una sal osmotica
AU2005313887B2 (en) * 2004-12-09 2011-10-27 Celgene Corporation Treatment using D-threo methylphenidate
WO2006081569A2 (fr) * 2005-01-27 2006-08-03 Alza Corporation Forme galenique osmotique orale comprenant une membrane a flux eleve
WO2006113568A2 (fr) * 2005-04-19 2006-10-26 Alza Corporation Combinaison de tramadol et de matieres renfermant la gabapentine
WO2007002872A2 (fr) * 2005-06-29 2007-01-04 Alza Corporation Compositions semi-permeables permettant de reduire le temps de sechage de formes posologiques osmotiques
WO2007106111A2 (fr) * 2005-07-01 2007-09-20 Elan Pharma International Limited Compositions nanoparticulaires et a liberation controlee comprenant de la nilvadipine
WO2007019393A2 (fr) * 2005-08-04 2007-02-15 Alza Corporation Formes posologiques osmotiques comprenant des membranes semi-permeables formees de melanges polymeres presentant des caracteristiques ameliorees
US8778395B2 (en) * 2005-08-11 2014-07-15 Andrx Labs, Llc Diltiazem controlled release formulation and method of manufacture
WO2007044234A1 (fr) * 2005-10-07 2007-04-19 Alza Corporation Forme posologique osmotique a aspects de liberation controlee et de liberation rapide
PL116330U1 (en) * 2005-10-31 2007-04-02 Alza Corp Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
US20070196487A1 (en) * 2006-02-16 2007-08-23 Geerke Johan H Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
CN102488652B (zh) 2006-03-16 2014-06-18 特瑞斯制药股份有限公司 含有药物-离子交换树脂复合物的经修饰释放的制剂
TW200815045A (en) * 2006-06-29 2008-04-01 Jazz Pharmaceuticals Inc Pharmaceutical compositions of ropinirole and methods of use thereof
WO2008021875A2 (fr) * 2006-08-08 2008-02-21 Accu-Break Technologies, Inc. Comprimé pharmaceutique contenant une pluralité de segments actifs
EP2119442A4 (fr) 2006-12-28 2010-12-15 Astellas Pharma Inc Composition pharmaceutique à libération entretenue de tacrolimus
US8524749B2 (en) * 2007-02-09 2013-09-03 Alza Corporation Controlled release compositions of tizanidine
WO2008105920A1 (fr) * 2007-02-28 2008-09-04 Collegium Pharmaceutical, Inc. Combinaison d'antihistaminiques
JP2011506318A (ja) 2007-12-06 2011-03-03 デュレクト コーポレーション 経口医薬製剤
JP2011511782A (ja) 2008-02-12 2011-04-14 アボット・ラボラトリーズ 長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
WO2009137827A2 (fr) * 2008-05-09 2009-11-12 Tiara Pharmaceuticals, Inc. Libération contrôlée de n-acétylcystéine (nac) en vue de la réduction de l'inflammation systémique et/ou vasculaire
MX2011000909A (es) * 2008-07-30 2011-02-23 Panacea Biotec Ltd Composiciones de ramipril de liberacion modificada y usos de las mismas.
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
WO2010077925A2 (fr) 2008-12-16 2010-07-08 Teva Pharmaceutical Industries Ltd. Système d'administration médicamenteuse d'ordre zéro, administration médicamenteuse biphasique d'ordre zéro, ascendante ou descendante de méthylphénidate
US8568793B2 (en) * 2009-02-11 2013-10-29 Hope Medical Enterprises, Inc. Sodium nitrite-containing pharmaceutical compositions
US9005661B2 (en) 2009-09-15 2015-04-14 Beijing Team Hospital Management Co., Ltd. Osmotic pump controlled release tablet and preparation method thereof
CA2789307A1 (fr) * 2010-03-29 2011-10-06 Hetero Research Foundation Composition pharmaceutique stable d'imatinib
EP2554168B1 (fr) 2010-03-29 2018-01-24 Astellas Pharma Inc. Composition pharmaceutique à libération contrôlée
US8287903B2 (en) 2011-02-15 2012-10-16 Tris Pharma Inc Orally effective methylphenidate extended release powder and aqueous suspension product
MX358059B (es) * 2012-01-17 2018-08-03 Croda Inc Aditivo de hinchamiento de sellos.
EP2884961B1 (fr) 2012-08-15 2019-03-06 Tris Pharma Inc. Comprimé à croquer de méthylphénidate à libération modifiée
CN105120659A (zh) 2013-03-15 2015-12-02 度瑞公司 用于降低溶解可变性的具有流变改性剂的组合物
CA2936740C (fr) 2014-10-31 2017-10-10 Purdue Pharma Methodes et compositions destinees au traitement du trouble de deficit d'attention
US11590228B1 (en) 2015-09-08 2023-02-28 Tris Pharma, Inc Extended release amphetamine compositions
JP7258561B2 (ja) 2016-07-06 2023-04-17 オリエント ファーマ シーオー.,エルティーディー. 薬物組成物、バリヤー層及び薬物層を有している経口投与形態
US9707217B1 (en) 2017-02-03 2017-07-18 Osmotica Kereskedelmi Es Szolgaltato Kft Dose-dumping resistant controlled release dosage form
US11590081B1 (en) 2017-09-24 2023-02-28 Tris Pharma, Inc Extended release amphetamine tablets
SG11202007825XA (en) 2018-02-16 2020-09-29 Esperion Therapeutics Inc Sustained release formulations of bempedoic acid
JP7195345B2 (ja) * 2018-03-05 2022-12-23 アムニール コンプレックス プロダクツ リサーチ エルエルシー 薬物の時間放出のためのプログラム可能な医薬組成物
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder
US11547670B2 (en) 2019-03-05 2023-01-10 Amneal Complex Products Research Llc Delayed release methylphenidate compositions
BR112022001645A2 (pt) 2019-08-12 2022-05-03 Massachusetts Inst Technology Artigo configurado para liberação de um agente terapêutico, e, métodos para distribuir fármaco intestinal e para administrar um agente terapêutico
CN114681422B (zh) * 2020-12-30 2023-09-05 深圳翰宇药业股份有限公司 一种硝苯地平控释片及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4093709A (en) * 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4318400A (en) * 1980-01-18 1982-03-09 Alza Corporation Medical infusor
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4863744A (en) * 1984-09-17 1989-09-05 Alza Corporation Intestine drug delivery
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
GB2206046B (en) * 1987-06-25 1991-04-03 Alza Corp Multi-unit delivery system
US4950486A (en) * 1987-10-02 1990-08-21 Alza Corporation Dosage form for treating cardiovascular diseases
US4892739A (en) * 1988-04-25 1990-01-09 Ciba-Geigy Corporation Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
US4966769A (en) * 1988-06-02 1990-10-30 Alza Corporation Method for delivering dosage form for diltiazem
JPH04503058A (ja) * 1989-01-30 1992-06-04 アルザ コーポレイション カルシウム拮抗体投与のための剤形
IE69174B1 (en) * 1989-01-31 1996-08-07 Int Pharma Agentur A system for the controlled release of active agents and a process for its preparation
US4984592A (en) * 1989-12-18 1991-01-15 Christine Hellein Manicure shield
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device

Also Published As

Publication number Publication date
NO930604D0 (no) 1993-02-22
PT98802A (pt) 1993-12-31
IE913023A1 (en) 1992-03-11
AU8500091A (en) 1992-03-30
ATE108999T1 (de) 1994-08-15
CA2088376A1 (fr) 1992-03-01
MX9100838A (es) 1992-04-01
EP0546038B1 (fr) 1994-07-27
PT98802B (pt) 1999-01-29
NO304580B1 (no) 1999-01-18
US5785994A (en) 1998-07-28
EP0546038A1 (fr) 1993-06-16
FI107699B (fi) 2001-09-28
US5156850A (en) 1992-10-20
JPH06500774A (ja) 1994-01-27
AU648822B2 (en) 1994-05-05
WO1992004011A1 (fr) 1992-03-19
CA2088376C (fr) 2001-05-01
NO930604L (no) 1993-02-26
FI930862L (fi) 1993-02-25
KR0162106B1 (ko) 1998-12-01
DE69103153D1 (de) 1994-09-01
KR930701156A (ko) 1993-06-11
DE69103153T2 (de) 1994-11-24
JP2796433B2 (ja) 1998-09-10
ES2056660T3 (es) 1994-10-01
IE67163B1 (en) 1996-03-06
ZA916802B (en) 1992-05-27
NZ239574A (en) 1993-10-26
FI930862A0 (fi) 1993-02-25

Similar Documents

Publication Publication Date Title
DK0546038T3 (da) Indgiftsform til tidsvarierende mønstre for lægemiddelafgivelse
SE8701900D0 (sv) Pulsed drug delivery
GR1002564B (el) Στερεα απο του στοματος χορηγουμενη φαρμακευτικη μορφη δοσιμετρησεως προγραμματισμενου ρυθμου απελευθερωσεως.
DE69527509D1 (de) Hydrogelformulierung mit gesteuerter freisetzung
DK1035834T3 (da) Osmotisk doseringsform omfattende en første og anden coating
GEP20063773B (en) Steroid Sulphatase Inhibitors
DE69636104D1 (de) Orale pharmazeutische Zusammensetzung mit verzögerter Wirkstofffreigabe von Protonenpumpen-Hemmern
ATE210474T1 (de) Implantierbare vorrichtung zur arzneiabgabe
HK1137355A1 (zh) 藥物劑量逐漸增加的劑型
ATE292453T1 (de) Antivirale arznei
MY103741A (en) Process for producing an administration and/or dosage form for medicinal active substances by means of a printing process
DE59608150D1 (de) Transdermales therapeutisches system (tts) zur verabreichung von testosteron
NO892764L (no) Medikamentell administreringsform for droevtyggere.
ES2187156T3 (es) Terapia antidepresiva.
MY100780A (en) Azumolene dosage form.
DE69626544D1 (de) Arzneistoffe
CA2125284A1 (fr) Formes de medicaments peptidiques pour administration perorale, notamment pour l'insuline
ATE116845T1 (de) Dosierungsform zur verabreichung von arzneimitteln für die zirkadiantherapie.
SE9500897D0 (sv) The pharmacological use of certain cystine derivatives
RU97117735A (ru) Способ лечения дифтерии
MX9605190A (es) Forma de dosis efectiva para farmacos antiepilepticos.
NO931208L (no) Formuleringer for transdermale kontraseptiver, samt fremgangsmaater og innretninger for tilfoersel av slike
MX9705324A (es) Sistema terapeutico transdermal para el suministro de (s)-3-metil-5-(1-metil-2-pirrolidenil)-isoxazol o alguna de sus sales farmaceuticamente aptas.
点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载